Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen and Genentech to Study Genetics of Cancer

NEW YORK, Dec. 6 (GenomeWeb News) - Perlegen Sciences announced today that it has begun a collaboration with Genentech to study the genetics of cancer.

 

The companies hope to apply findings to the discovery and development of targeted medicines and molecular diagnostics for cancer.

 

Perlegen uses Affymetrix's GeneChip technology in its high-throughput oligonucleotide array approach.

 

Terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more